These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 7479695)

  • 21. The 1.5 A crystal structure of a prokaryote serpin: controlling conformational change in a heated environment.
    Irving JA; Cabrita LD; Rossjohn J; Pike RN; Bottomley SP; Whisstock JC
    Structure; 2003 Apr; 11(4):387-97. PubMed ID: 12679017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dimers initiate and propagate serine protease inhibitor polymerisation.
    Zhou A; Carrell RW
    J Mol Biol; 2008 Jan; 375(1):36-42. PubMed ID: 18005992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insight into the mechanism of serpin-proteinase inhibition from 2D [1H-15N] NMR studies of the 69 kDa alpha 1-proteinase inhibitor Pittsburgh-trypsin covalent complex.
    Peterson FC; Gettins PG
    Biochemistry; 2001 May; 40(21):6284-92. PubMed ID: 11371190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of the plasma elimination kinetics and conformational stabilities of native, proteinase-complexed, and reactive site cleaved serpins: comparison of alpha 1-proteinase inhibitor, alpha 1-antichymotrypsin, antithrombin III, alpha 2-antiplasmin, angiotensinogen, and ovalbumin.
    Mast AE; Enghild JJ; Pizzo SV; Salvesen G
    Biochemistry; 1991 Feb; 30(6):1723-30. PubMed ID: 1704258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Divining the serpin inhibition mechanism: a suicide substrate 'springe'?
    Engh RA; Huber R; Bode W; Schulze AJ
    Trends Biotechnol; 1995 Dec; 13(12):503-10. PubMed ID: 8595135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural basis of latency in plasminogen activator inhibitor-1.
    Mottonen J; Strand A; Symersky J; Sweet RM; Danley DE; Geoghegan KF; Gerard RD; Goldsmith EJ
    Nature; 1992 Jan; 355(6357):270-3. PubMed ID: 1731226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
    Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W
    J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The P6-P2 region of serpins is critical for proteinase inhibition and complex stability.
    Chaillan-Huntington CE; Gettins PG; Huntington JA; Patston PA
    Biochemistry; 1997 Aug; 36(31):9562-70. PubMed ID: 9236002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conformational changes in serpins: I. The native and cleaved conformations of alpha(1)-antitrypsin.
    Whisstock JC; Skinner R; Carrell RW; Lesk AM
    J Mol Biol; 2000 Jan; 295(3):651-65. PubMed ID: 10623554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crystal structure of an uncleaved serpin reveals the conformation of an inhibitory reactive loop.
    Wei A; Rubin H; Cooperman BS; Christianson DW
    Nat Struct Biol; 1994 Apr; 1(4):251-8. PubMed ID: 7656054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Understanding the specificity of serpin-protease complexes through interface analysis.
    Rashid Q; Kapil C; Singh P; Kumari V; Jairajpuri MA
    J Biomol Struct Dyn; 2015; 33(6):1352-62. PubMed ID: 25052369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apical and non-polarized secretion of serpins from MDCK cells.
    Vogel LK; Larsen JE
    FEBS Lett; 2000 May; 473(3):297-302. PubMed ID: 10818229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distal hinge of plasminogen activator inhibitor-1 involves its latency transition and specificities toward serine proteases.
    Wang Q; Shaltiel S
    BMC Biochem; 2003 Jul; 4():5. PubMed ID: 12848892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential effects of heparin and glucose on structural conformation of human alpha1 antitrypsin: evidence for a heparin-induced cleaved form of the inhibitor.
    Finotti P; de Laureto PP
    Arch Biochem Biophys; 1997 Nov; 347(1):19-29. PubMed ID: 9344460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein inhibitors of serine proteinases.
    Otlewski J; Krowarsch D; Apostoluk W
    Acta Biochim Pol; 1999; 46(3):531-65. PubMed ID: 10698264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bypassing the kinetic trap of serpin protein folding by loop extension.
    Im H; Ahn HY; Yu MH
    Protein Sci; 2000 Aug; 9(8):1497-502. PubMed ID: 10975571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Engineering an anion-binding cavity in antichymotrypsin modulates the "spring-loaded" serpin-protease interaction.
    Lukacs CM; Rubin H; Christianson DW
    Biochemistry; 1998 Mar; 37(10):3297-304. PubMed ID: 9521649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A 2.6 A structure of a serpin polymer and implications for conformational disease.
    Huntington JA; Pannu NS; Hazes B; Read RJ; Lomas DA; Carrell RW
    J Mol Biol; 1999 Oct; 293(3):449-55. PubMed ID: 10543942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The reactive site loop of the serpin SCCA1 is essential for cysteine proteinase inhibition.
    Schick C; Brömme D; Bartuski AJ; Uemura Y; Schechter NM; Silverman GA
    Proc Natl Acad Sci U S A; 1998 Nov; 95(23):13465-70. PubMed ID: 9811823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Purification and characterization of Manduca sexta serpin-6: a serine proteinase inhibitor that selectively inhibits prophenoloxidase-activating proteinase-3.
    Wang Y; Jiang H
    Insect Biochem Mol Biol; 2004 Apr; 34(4):387-95. PubMed ID: 15041022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.